Evidence map›Paper›PMID 39714139›Full record

ArticleMicrobiology spectrum2025

Another way? An investigation into an institution's use of the Wayson stain in re-evaluating "no organisms seen" on Gram stain smears from positive blood cultures.

Christopher C Attaway, Jessica Smith, Daniel D Rhoads

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher C AttawayDepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.ORCID 0000-0002-9135-7747
Jessica SmithPathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Daniel D RhoadsPathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0002-7636-5191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automated continuous monitoring blood culture instruments identify metabolism byproducts and flag blood culture bottles as "positive." A Gram stain is used to visualize and characterize the microbial growth in the broth and initiate additional testing. When no organisms are seen (NOS) on Gram stain, in our laboratory, bottles are reevaluated with a Wayson stain, a rapid one-step stain that provides contrast between organisms and the background, especially in Gram-negative organisms. In this study, we assess the performance of the Wayson stain on reevaluation of Gram stain NOS blood culture bottles. The study period, August 2022 to July 2023, includes blood cultures that were flagged as positive by the automated blood culture instrument (BACTEC) with accompanying Gram and Wayson stain interpretations and organism identification. 133,463 blood cultures were performed during the study period, and 20,129 cultures were flagged as positive by BACTEC. 601 NOS Gram stain cultures were identified of which 76 had a positive Wayson. The Wayson stain procedure increased the sensitivity of direct organism visualization from 99.32% to 99.71% by identifying 55% (76 of 137) of NOS Gram stain blood culture bottles. Of blood cultures that were positive by BACTEC with NOS Gram and Wayson stains (475), 414 were finalized as no growth and 61 had an isolate (false negatives) of which 49% (30) were yeasts. The Wayson stain aided in detecting gram-negative genera such as

Indexed as

BacteremiaBacteriological TechniquesBlood CultureGentian VioletStaining and LabelingGram-Negative BacteriaHumansPhenazinesSensitivity and SpecificityGentian VioletGram's stainPhenazinesbacteriologyblood culturesclinical methodsGram-negativewayson stain

Identifiers

PMID39714139
PMCPMC11792467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.